Masimo Corporation (MASI)

Masimo Corporation, founded in 1989 by Joe Kiani, is a global medical technology company renowned for its innovative noninvasive patient monitoring technologies. Headquartered in Irvine, California, Masimo is best known for its signal extraction technology (SET) pulse oximetry, which has revolutionized how patient monitoring is conducted by providing more accurate and reliable measurements even in challenging conditions. The company has steadily expanded its product offerings to include various monitoring and automation solutions for both hospital and home settings. Masimo's CEO, Joe Kiani, remains a driving force behind the company's mission to improve patient outcomes and reduce the cost of care by leveraging technology. In 2022, the company reported revenues of over $1 billion, reflecting its strong market presence and continued growth. Masimo continues to be a leading player in the healthcare industry, actively advancing technologies to improve the quality of patient care worldwide.